57
34
Growth Score
-2 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
344788
CTMC is a clinical cancer center to enable innovation from academia and biotech to accelerate cell therapy’s impact on cancer patients.
- Jason Bock: Co-Founder and CEOPast Role: MD Anderson Cancer Center, Vice President and Head of Biologics Product Development, Therapeutics Discovery
- Houman Mesghali: Co-Founder and COOPast Role: MD Anderson Cancer Center, Head of Biologics Portfolio and Alliance Management
About the Company
CTMC, also known as Cell Therapy Manufacturing Center, operates in the biopharma, biotechnology, and therapeutics industries. It is a joint venture between Resilience and MD Anderson Cancer Center. The organization focuses on the manufacturing of complex biologics, with a particular emphasis on cell therapy. CTMC aims to accelerate cell therapy
development and manufacturing to reach patients faster. It maintains an open and continuous dialogue with partners, media, and the general public to ensure timely, transparent communication. CTMC also conducts informational webinars that are open to anyone interested, providing further insight into their work and progress.
